We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

42 hedge funds and large institutions have $181M invested in Oxford Immunotec Global PLC Ordinary Shares in 2013 Q4 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
+42
Holders Change %
–
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
42
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$16.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$15.1M
3
Invesco
Invesco
Georgia
+$9.73M
4
LPLP
Lansdowne Partners Limited Partnership
United Kingdom
+$9.24M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$8.15M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CV
1
Clarus Ventures
Massachusetts
$50M +$45.6M +2,579,062 New
RG
2
Redmile Group
California
$18.3M +$16.7M +946,457 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$16.5M +$15.1M +853,900 New
Invesco
4
Invesco
Georgia
$10.7M +$9.73M +550,000 New
LPLP
5
Lansdowne Partners Limited Partnership
United Kingdom
$10.1M +$9.24M +522,354 New
FI
6
Fosun International
China
$9.06M +$8.27M +467,551 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$8.94M +$8.15M +461,085 New
DCC
8
Dow Chemical Company
Michigan
$7.17M +$6.55M +370,148 New
BA
9
BlackRock Advisors
Delaware
$6.03M +$5.5M +310,958 New
PC
10
Polar Capital
United Kingdom
$5.83M +$5.32M +301,078 New
TCM
11
Tamarack Capital Management
California
$5.33M +$4.86M +275,000 New
FCM
12
Farallon Capital Management
California
$4.59M +$4.19M +237,000 New
WSA
13
Wall Street Associates
California
$3.45M +$3.15M +178,000 New
BFA
14
BlackRock Fund Advisors
California
$3.19M +$2.91M +164,666 New
KCM
15
Kornitzer Capital Management
Kansas
$2.96M +$2.7M +152,612 New
BG
16
BlackRock Group
United Kingdom
$2.72M +$2.48M +140,400 New
Wells Fargo
17
Wells Fargo
California
$2.54M +$2.32M +131,220 New
Deutsche Bank
18
Deutsche Bank
Germany
$2.21M +$2.02M +114,071 New
DCM
19
Driehaus Capital Management
Illinois
$2M +$1.82M +103,023 New
Axa
20
Axa
France
$1.45M +$1.33M +75,000 New
Northern Trust
21
Northern Trust
Illinois
$1.42M +$1.3M +73,328 New
BIM
22
BlackRock Investment Management
Delaware
$1.2M +$1.1M +62,136 New
BIT
23
BlackRock Institutional Trust
California
$1.14M +$1.04M +58,711 New
State Street
24
State Street
Massachusetts
$1.02M +$931K +52,613 New
GP
25
Grow Partners
California
$969K +$884K +50,000 New
1
2

OXFD Hedge Fund Activity: Q4 2013 in Review

42 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2013, worth a combined $181M.

Buyers outnumbered sellers: 42 funds opened new OXFD positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $16.7M.

  • 42 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2013, up from 0 in Q3 2013.
  • Funds reported $181M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2013.
  • 42 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2013 and 0 closed out, a net change of +42 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2013 was Redmile Group, an estimated $16.7M added.

Based on aggregated 13F filings for Q4 2013.